Vivasure Medical closes $23m tranche

Vivasure Medical, a provider of absorbable technology for percutaneous vessel closure, has closed the first $23 million tranche as part of its Series D funding that could reach up to $54 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this